47 related articles for article (PubMed ID: 28702132)
1. Transcriptional level evaluation of osteopontin/miRNA-181a axis in hepatocellular carcinoma cell line-secreted extracellular vesicles.
Cabiati M; Di Giorgi N; Salvadori C; Finamore F; Del Turco S; Cecchettini A; Rocchiccioli S; Del Ry S
Pathol Res Pract; 2022 Oct; 238():154088. PubMed ID: 36084428
[TBL] [Abstract][Full Text] [Related]
2. Role of plasma osteopontin as a biomarker in locally advanced breast cancer.
Anborgh PH; Caria LB; Chambers AF; Tuck AB; Stitt LW; Brackstone M
Am J Transl Res; 2015; 7(4):723-32. PubMed ID: 26064440
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma.
Pang BY; Leng Y; Wang X; Wang YQ; Jiang LH
Ann Med; 2023 Dec; 55(1):42-61. PubMed ID: 36476015
[TBL] [Abstract][Full Text] [Related]
4. The Most Promising Biomarkers of Allogeneic Kidney Transplant Rejection.
Rogulska K; Wojciechowska-Koszko I; Dołęgowska B; Kwiatkowska E; Roszkowska P; Kapczuk P; Kosik-Bogacka D
J Immunol Res; 2022; 2022():6572338. PubMed ID: 35669103
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin as a biomarker for COVID-19 severity and multisystem inflammatory syndrome in children: A pilot study.
Reisner A; Blackwell LS; Sayeed I; Myers HE; Wali B; Heilman S; Figueroa J; Lu A; Hussaini L; Anderson EJ; Shane AL; Rostad CA
Exp Biol Med (Maywood); 2022 Jan; 247(2):145-151. PubMed ID: 34565198
[TBL] [Abstract][Full Text] [Related]
6. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Experimental Evaluation of Diagnostic Significance of Alpha-Fetoprotein and Osteopontin at the Early Stage of Hepatocellular Cancer.
Macek-Jilkova Z; Malov SI; Kurma K; Charrat C; Decaens T; Peretolchina NP; Marche PN; Malov IV; Yushchuk ND
Bull Exp Biol Med; 2021 Jan; 170(3):340-344. PubMed ID: 33452981
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma.
Wang X; Yu T; Liao X; Yang C; Han C; Zhu G; Huang K; Yu L; Qin W; Su H; Liu X; Peng T
Cancer Med; 2018 Apr; 7(4):966-980. PubMed ID: 29479826
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis.
Sun T; Tang Y; Sun D; Bu Q; Li P
Onco Targets Ther; 2018; 11():8925-8935. PubMed ID: 30573979
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin -- a promising biomarker for cancer therapy.
Wei R; Wong JPC; Kwok HF
J Cancer; 2017; 8(12):2173-2183. PubMed ID: 28819419
[TBL] [Abstract][Full Text] [Related]
11. Measuring levels of osteopontin as potential biomarker for hepatocellular carcinoma in Syrian patients.
Al-Zoubi S; Wassouf A; Zetoune AB
Gastroenterol Hepatol Bed Bench; 2017; 10(2):97-101. PubMed ID: 28702132
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
Kim J; Ki SS; Lee SD; Han CJ; Kim YC; Park SH; Cho SY; Hong YJ; Park HY; Lee M; Jung HH; Lee KH; Jeong SH
Am J Gastroenterol; 2006 Sep; 101(9):2051-9. PubMed ID: 16848813
[TBL] [Abstract][Full Text] [Related]
13. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
Nabih MI; Aref WM; Fathy MM
Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
[TBL] [Abstract][Full Text] [Related]
14. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma.
Lee HJ; Yeon JE; Suh SJ; Lee SJ; Yoon EL; Kang K; Yoo YJ; Kim JH; Seo YS; Yim HJ; Byun KS
Gut Liver; 2014 Mar; 8(2):177-85. PubMed ID: 24672660
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
